Volume 24 - Issue 5 - May 2016
News
News
06/02/2016
Click here to see the answer.
Click here to see the answer.
Click here to see the...
06/02/2016
The Dermatologist
News
05/28/2016
Click here to see the answer.
Click here to see the answer.
Click here to see the answer.
05/28/2016
The Dermatologist
News
05/26/2016
A recent study evaluated detailed drug utilization in patients with psoriasis compared with controls in a population-based sample.
A recent study evaluated detailed drug utilization in patients with psoriasis compared with controls in a population-based sample.
A recent study evaluated...
05/26/2016
The Dermatologist
Department
Derm Dx
06/02/2016
A 64-year-old man presented for management of his chronic skin condition on the scalp.
A 64-year-old man presented for management of his chronic skin condition on the scalp.
A 64-year-old man presented for...
06/02/2016
The Dermatologist
Board Review
05/24/2016
The contents of these questions are taken from the Galderma Pre-Board Webinar. The Pre-Board Webinar is now an online course. For details, go to www.pre-board.com. The program will be available from April 15, 2016 to November 15, 2016....
The contents of these questions are taken from the Galderma Pre-Board Webinar. The Pre-Board Webinar is now an online course. For details, go to www.pre-board.com. The program will be available from April 15, 2016 to November 15, 2016....
The contents of these questions...
05/24/2016
The Dermatologist
06/02/2016
This review looks at new research results and trends in therapies for skin cancer.
This review looks at new research results and trends in therapies for skin cancer.
This review looks at new...
06/02/2016
The Dermatologist
06/01/2016
Juvéderm Volbella XC (Allergan) received FDA approval for use in the lips for lip augmentation and for correction of perioral rhytids, or perioral lines, in adults over the age of 21.
Juvéderm Volbella XC (Allergan) received FDA approval for use in the lips for lip augmentation and for correction of perioral rhytids, or perioral lines, in adults over the age of 21.
Juvéderm Volbella XC (Allergan)...
06/01/2016
The Dermatologist
05/31/2016
Pfizer Inc. and Anacor Pharmaceuticals, Inc. have entered into a definitive merger agreement under which Pfizer will acquire Anacor.
Pfizer Inc. and Anacor Pharmaceuticals, Inc. have entered into a definitive merger agreement under which Pfizer will acquire Anacor.
Pfizer Inc. and Anacor...
05/31/2016
The Dermatologist
Interactive Features
FDA Alerts
05/27/2016
A recently-approved plaque psoriasis drug is predicted to generate sales more than $1 billion in the US and Europe.
A recently-approved plaque psoriasis drug is predicted to generate sales more than $1 billion in the US and Europe.
A recently-approved plaque...
05/27/2016
The Dermatologist
Column
Therapeutic Review
05/24/2016
Posters included recent research covering a variety of aspects of atopic dermatitis.
Posters included recent research covering a variety of aspects of atopic dermatitis.
Posters included recent research...
05/24/2016
The Dermatologist
